- 全部删除
- 您的购物车当前为空
Rituximab 是抗 CD20 嵌合单克隆抗体,用于研究某些自身免疫疾病和癌症。
Rituximab 是抗 CD20 嵌合单克隆抗体,用于研究某些自身免疫疾病和癌症。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,590 | In stock | |
5 mg | ¥ 3,980 | In stock | |
10 mg | ¥ 5,680 | In stock |
Rituximab 相关产品
产品描述 | Rituximab is an anti-CD20 chimeric monoclonal antibody used to study certain autoimmune diseases and cancers. |
靶点活性 | Ramos cells:1 ± 0.1 nM (0.15 mg/ml), RL cells:1.5 ± 0.1 nM (0.22 mg/ml) |
体外活性 | 方法:使用 0、2.5、5 和 10 μg/mL Rituximab处理B细胞,观察Rituximab对B细胞增值的影响。 |
体内活性 | 方法:在4小时内给予肿瘤患者 100 mg Rituximab。然后以每周 3 次的方案输注,持续 4 周,并在患者中检查caspase-3和PARP的表达和蛋白水解过程。 |
细胞实验 | Objective: Complement-mediated cell lysis. Concentrations: 0, 0.02, 0.2, 2, 20 μg/mL. Incubation Time: 2 h. Method: Lymphoma B cells were purified from lymph node biopsies of patients with B-cell lymphoma. Rituximab was added to tumor cells (1×106 /mL) in complete medium supplemented by human serum, inactivated or not by incubation at 56°C for 30 minutes. After 2 hours at 37°C, cell lysis was determined by PI staining of cells and analysis by flow cytometry. |
别名 | 利妥昔单抗 |
分子量 | 148 kDa |
CAS No. | 174722-31-7 |
密度 | no data available |
存储 | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
Crystal structure of Rituximab Fab in complex with an epitope peptide
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容